- Home
- TSVT vs SABA Comparison
TSVT vs SABA Comparison
Compare TSVT & SABA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TSVT
- SABA
- Stock Information
- Founded
- TSVT 2021
- SABA 1988
- Country
- TSVT United States
- SABA United States
- Employees
- TSVT N/A
- SABA N/A
- Industry
- TSVT Biotechnology: Pharmaceutical Preparations
- SABA
- Sector
- TSVT Health Care
- SABA
- Exchange
- TSVT Nasdaq
- SABA Nasdaq
- Market Cap
- TSVT 253.9M
- SABA 243.6M
- IPO Year
- TSVT N/A
- SABA N/A
- Fundamental
- Price
- TSVT $4.98
- SABA $8.59
- Analyst Decision
- TSVT Buy
- SABA
- Analyst Count
- TSVT 6
- SABA 0
- Target Price
- TSVT $10.40
- SABA N/A
- AVG Volume (30 Days)
- TSVT 340.7K
- SABA 290.0K
- Earning Date
- TSVT 11-12-2024
- SABA 01-01-0001
- Dividend Yield
- TSVT N/A
- SABA 12.91%
- EPS Growth
- TSVT N/A
- SABA N/A
- EPS
- TSVT N/A
- SABA N/A
- Revenue
- TSVT $44,120,000.00
- SABA N/A
- Revenue This Year
- TSVT N/A
- SABA N/A
- Revenue Next Year
- TSVT $22.42
- SABA N/A
- P/E Ratio
- TSVT N/A
- SABA N/A
- Revenue Growth
- TSVT N/A
- SABA N/A
- 52 Week Low
- TSVT $1.54
- SABA $3.64
- 52 Week High
- TSVT $6.40
- SABA $4.42
- Technical
- Relative Strength Index (RSI)
- TSVT 56.21
- SABA 55.46
- Support Level
- TSVT $4.60
- SABA $8.51
- Resistance Level
- TSVT $5.10
- SABA $8.66
- Average True Range (ATR)
- TSVT 0.28
- SABA 0.09
- MACD
- TSVT 0.02
- SABA 0.00
- Stochastic Oscillator
- TSVT 83.54
- SABA 58.97
About TSVT 2seventy bio Inc.
2seventy bio Inc is a cell and gene therapy company focused on the research, development, and commercialization of transformative treatments for cancer. The company operates in a single segment, focusing on researching, developing and commercializing potentially transformative treatments for cancer.
About SABA Saba Capital Income & Opportunities Fund II Shares of Beneficial Interest
Templeton Global Income Fund is a closed-end fund. It seeks high current income, with a secondary goal of capital appreciation. Under normal market conditions. The Fund invests at least over 80% of its net assets in income-producing securities, including debt securities of the United States and foreign issuers, including emerging markets.